These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26143971)

  • 1. Transfer of opiorphin through a blood-brain barrier culture model.
    Bocsik A; Darula Z; Tóth G; Deli MA; Wollemann M
    Arch Med Res; 2015 Aug; 46(6):502-6. PubMed ID: 26143971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Opiorphin, a natural antinociceptive modulator of opioid-dependent pathways.
    Wisner A; Dufour E; Messaoudi M; Nejdi A; Marcel A; Ungeheuer MN; Rougeot C
    Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17979-84. PubMed ID: 17101991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of synthetic analogues of human opiorphin on rat brain opioid receptors.
    Benyhe Z; Toth G; Wollemann M; Borsodi A; Helyes Z; Rougeot C; Benyhe S
    J Physiol Pharmacol; 2014 Aug; 65(4):525-30. PubMed ID: 25179084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemically active human opiorphin is a potent yet non-addictive analgesic without drug tolerance effects.
    Rougeot C; Robert F; Menz L; Bisson JF; Messaoudi M
    J Physiol Pharmacol; 2010 Aug; 61(4):483-90. PubMed ID: 20814077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human opiorphin is a naturally occurring antidepressant acting selectively on enkephalin-dependent delta-opioid pathways.
    Javelot H; Messaoudi M; Garnier S; Rougeot C
    J Physiol Pharmacol; 2010 Jun; 61(3):355-62. PubMed ID: 20610867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STR-324, a Stable Analog of Opiorphin, Causes Analgesia in Postoperative Pain by Activating Endogenous Opioid Receptor-dependent Pathways.
    Sitbon P; Van Elstraete A; Hamdi L; Juarez-Perez V; Mazoit JX; Benhamou D; Rougeot C
    Anesthesiology; 2016 Nov; 125(5):1017-1029. PubMed ID: 27571257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opiorphin causes a panicolytic-like effect in rat panic models mediated by μ-opioid receptors in the dorsal periaqueductal gray.
    Maraschin JC; Rangel MP; Bonfim AJ; Kitayama M; Graeff FG; Zangrossi H; Audi EA
    Neuropharmacology; 2016 Feb; 101():264-70. PubMed ID: 26363194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opiorphin increases blood pressure of conscious rats through renin-angiotensin system (RAS).
    Fang Y; Li S; Zhou H; Tian X; Lv S; Chen Q
    Peptides; 2014 May; 55():47-51. PubMed ID: 24486428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B2-kinin receptors in the dorsal periaqueductal gray are implicated in the panicolytic-like effect of opiorphin.
    Sestile CC; Maraschin JC; Rangel MP; Santana RG; Zangrossi H; Graeff FG; Audi EA
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):493-498. PubMed ID: 28797641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opiorphin highly improves the specific binding and affinity of MERF and MEGY to rat brain opioid receptors.
    Tóth F; Tóth G; Benyhe S; Rougeot C; Wollemann M
    Regul Pept; 2012 Oct; 178(1-3):71-5. PubMed ID: 22771829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of electroencephalographic changes in response to acute electrical and thermal stimuli with the tail flick and hot plate test in rats administered with opiorphin.
    Singh P; Kongara K; Harding D; Ward N; Dukkipati VSR; Johnson C; Chambers P
    BMC Neurol; 2018 Apr; 18(1):43. PubMed ID: 29673329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects and underlying mechanisms of human opiorphin on colonic motility and nociception in mice.
    Tian XZ; Chen J; Xiong W; He T; Chen Q
    Peptides; 2009 Jul; 30(7):1348-54. PubMed ID: 19442408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human opiorphin: the lack of physiological dependence, tolerance to antinociceptive effects and abuse liability in laboratory mice.
    Popik P; Kamysz E; Kreczko J; Wróbel M
    Behav Brain Res; 2010 Nov; 213(1):88-93. PubMed ID: 20438769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pericytes from brain microvessels strengthen the barrier integrity in primary cultures of rat brain endothelial cells.
    Nakagawa S; Deli MA; Nakao S; Honda M; Hayashi K; Nakaoke R; Kataoka Y; Niwa M
    Cell Mol Neurobiol; 2007 Sep; 27(6):687-94. PubMed ID: 17823866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the effects of opiorphin and sialorphin and their analogs substituted in position 1 with pyroglutamic acid on motility in the mouse ileum.
    Kamysz E; Sałaga M; Sobczak M; Kamysz W; Fichna J
    J Pept Sci; 2013 Mar; 19(3):166-72. PubMed ID: 23381913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.
    Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M
    Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transport characteristics of endomorphin-2 analogues in brain capillary endothelial cells.
    Mallareddy JR; Tóth G; Fazakas C; Molnár J; Nagyőszi P; Lipkowski AW; Krizbai IA; Wilhelm I
    Chem Biol Drug Des; 2012 Apr; 79(4):507-13. PubMed ID: 22181340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MEL-N16: A Series of Novel Endomorphin Analogs with Good Analgesic Activity and a Favorable Side Effect Profile.
    Liu X; Zhao L; Wang Y; Zhou J; Wang D; Zhang Y; Zhang X; Wang Z; Yang D; Mou L; Wang R
    ACS Chem Neurosci; 2017 Oct; 8(10):2180-2193. PubMed ID: 28732166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opiorphin in burning mouth syndrome patients: a case-control study.
    Salarić I; Sabalić M; Alajbeg I
    Clin Oral Investig; 2017 Sep; 21(7):2363-2370. PubMed ID: 28013436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opiorphin levels in fluids of burning mouth syndrome patients: a case-control study.
    Boucher Y; Braud A; Dufour E; Agbo-Godeau S; Baaroun V; Descroix V; Guinnepain MT; Ungeheuer MN; Ottone C; Rougeot C
    Clin Oral Investig; 2017 Sep; 21(7):2157-2164. PubMed ID: 27834029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.